Cat. No. 1157
Biological ActivityEndogenous peptide; inhibits the release of growth hormone, insulin and glucagon. Inhibits voltage-dependent calcium channels.
(Modifications: Disulfide bridge between 3 - 14)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Alderton et al (1998) Differential effects of somatostatin and angiopeptin on cell proliferation. Br.J.Pharmacol. 124 323. PMID: 9641549.
Ohmura et al (1990) Somatostatin decreases the calcium inward current in guinea-pig atria. Br.J.Pharmacol. 99 587. PMID: 1970502.
Dileepan et al (1985) Somatostatin: a metabolic regulator. Life Sci. 37 2335. PMID: 2867445.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Somatostatin include:
Chiu et al (2013) Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501 52. PMID: 23965627.
Do you know of a great paper that uses Somatostatin from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Somatostatin, supplier, Influences, growth, hormone, release, sst, Receptors, Somatostatin, Tocris Bioscience, Somatostatin (sst) Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.